ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,441.93
      0.35%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      08/02/20228:05AMTipRanksHere’s Why Lexicon Stock Rallied 7.6% in Monday’s Extended TradeNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20224:17PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20224:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/29/20228:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 2, 2022NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/28/20227:00AMGlobeNewswire Inc.Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private PlacementNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/27/20224:01PMGlobeNewswire Inc.Lexicon Announces Proposed Public Offering Of Common StockNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/27/202212:15PMTipRanksAnalysts Offer Insights on Healthcare Companies: Integra Lifesciences (IART) and Lexicon Pharmaceuticals (LXRX)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/27/20227:59AMGlobeNewswire Inc.Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/30/202212:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/30/202212:15PMTipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Lexicon Pharmaceuticals (LXRX) and Heron Therapeutics (HRTX)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/30/202211:07AMDow Jones NewsLexicon Pharmaceuticals Shares Drop 10% After Trial Results for LX9211NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/29/20224:01PMGlobeNewswire Inc.Lexicon Announces Positive Top-Line Results From Phase 2 Proof-Of-Concept Study Of LX9211 In Painful Diabetic NeuropathyNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/01/20228:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the Jefferies 2022 Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/31/20228:42AMDow Jones NewsLexicon Refiles FDA Application for Sotagliflozin in Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/31/20228:00AMGlobeNewswire Inc.Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20224:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/23/20224:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/05/20224:13PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/05/202211:15AMTipRanksAnalysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Horizon Therapeutics (HZNP) and Autolus Therapeutics (AUTL)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/05/20226:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/02/20224:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/02/20224:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/02/20224:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/02/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX